GSK hails positive phase III trial results for RSV vaccine candidate
(Alliance News) - GSK PLC on Thursday said a New England Journal of Medicine publication announced positive results of a phase III trial for its respiratory syncytial virus vaccine candidate for older adults .
GSK said it is on track for…